Abstract

Exploring the molecular mechanisms that prevent inflammation during caloric restriction may yield promising therapeutic targets. During fasting, activation of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) promotes the utilization of lipids as an energy source. Herein, we show that ligand activation of PPARα directly upregulates the long non-coding RNA gene Gm15441 through PPARα binding sites within its promoter. Gm15441 expression suppresses its antisense transcript, encoding thioredoxin interacting protein (TXNIP). This, in turn, decreases TXNIP-stimulated NLR family pyrin domain containing 3 (NLRP3) inflammasome activation, caspase-1 (CASP1) cleavage, and proinflammatory interleukin 1β (IL1B) maturation. Gm15441-null mice were developed and shown to be more susceptible to NLRP3 inflammasome activation and to exhibit elevated CASP1 and IL1B cleavage in response to PPARα agonism and fasting. These findings provide evidence for a mechanism by which PPARα attenuates hepatic inflammasome activation in response to metabolic stress through induction of lncRNA Gm15441.

PPAR-alpha is a ligand responsive transcription factor that mediates energy metabolism during fasting in the liver. Here the authors show that Gm15441 is a PPAR-alpha dependent lncRNA that prevents the expression of its antisense transcript, thioredoxin interacting protein (TXNIP), and attenuates inflammasome activation.

Details

Title
Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting
Author
Brocker, Chad N 1   VIAFID ORCID Logo  ; Kim, Donghwan 1 ; Melia Tisha 2   VIAFID ORCID Logo  ; Karri Kritika 2 ; Velenosi, Thomas J 1 ; Takahashi, Shogo 3   VIAFID ORCID Logo  ; Aibara Daisuke 1 ; Bonzo, Jessica A 1 ; Levi, Moshe 4   VIAFID ORCID Logo  ; Waxman, David J 2   VIAFID ORCID Logo  ; Gonzalez, Frank J 1   VIAFID ORCID Logo 

 National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 Boston University, Department of Biology and Bioinformatics Program, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558) 
 National Institutes of Health, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165); Georgetown University, Biochemistry and Molecular & Cellular Biology, Washington, USA (GRID:grid.213910.8) (ISNI:0000 0001 1955 1644) 
 Georgetown University, Biochemistry and Molecular & Cellular Biology, Washington, USA (GRID:grid.213910.8) (ISNI:0000 0001 1955 1644) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471571175
Copyright
© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.